Back to Top

"One of today's leaders in investor relations and shareholder services"

Tag Archives: Hemp

ChineseInvestors.com, Inc. Announces that its Subsidiary ChineseHempOil.com, Inc. Launched its OptHemp Product Line on Amazon for Singles Day 2017

SAN GABRIEL, California, November 14, 2017 /PRNewswire/ — ChineseInvestors.com, Inc. (OTCQB: CIIX) (“CIIX” or the “Company”), the premier financial information website for Chinese-speaking investors, today announced that its wholly owned subsidiary ChineseHempOil.com, Inc. launched its OptHemp product line on Amazon.com kicking off a multi-channel campaign geared to both the US and Chinese-American markets during the 9th annual Singles Day Celebration. 

This commences the e-commerce marketplace initiative that the Company set into motion in early June through a strategic partnership with Quiverr Collective (“Quiverr”), a subsidiary of Advantage Solutions. Quiverr is a top 100, platinum level partner seller on Amazon Marketplace and has agreed to include the OptHemp product line in its limited catalog for resale through the Amazon Channel.  As a wholly owned subsidiary of Advantage Solutions, Quiverr brings tremendous resources and knowledge and specified capabilities to drive sales on the Amazon channel using performance-based resale model.  Advantage Solutions is …

Continue Reading

Posted in Client News| Tagged , |

Medical Marijuana, Inc. Subsidiary Kannaway® Announces New Hemp-Based SuperGreens

SAN DIEGO, Nov. 8, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) announced today that subsidiary Kannaway, LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, has introduced Kannaway® SuperGreens, a brand new way to take advantage of hemp’s nutritional benefits.

Kannaway® SuperGreens is formulated with more than 40 different superfood and nutrient dense ingredients, Kannaway® SuperGreens makes it easier to get the suggested daily intake of vitamins, minerals, fiber, protein, and other nutrients by using products such as wheat, barley, and alfalfa grasses, spinach, broccoli, kale, acai, carrot, beet, turmeric, flax and chia seeds, hemp flour, and Kannaway’s exclusive Bi-Bong® herbal extracts.

“We are very pleased to be able to offer our many loyal customers the option to have a healthy meal on-the-go as an alternative to traditional fast food options,” said Kannaway CEO Blake Schroeder. “This product combines numerous benefits with the many …

Continue Reading

Posted in Client News| Tagged , |
HempMeds® Brazil

HempMeds Brazil Scores Key Legal Victory and Gains Notoriety

HempMeds® Brazil

Medical Marijuana Inc. (OTC MJNA) has received recognition over the past year for its innovative products and successful marketing, which have made it a forerunner in the field of medicinal marijuana. The company and its subsidiary, Kannaway, accomplished record sales over the course of the past year. Now, another of Medical Marijuana Inc.’s subsidiaries, HempMeds®, is proving itself as a revolutionary as well, reforming the traditional views on marijuana in Brazil.

Who is HempMeds® Brazil?

HempMeds® is a subsidiary of Medical Marijuana Inc., which is a company that focuses on cannabis and hemp products. HempMeds® Brazil is the first company to gain legal approval to ship cannabis-related products into Brazil. All three products currently manufactured by HempMeds® Brazil are subsidized under Brazil’s health care system through the government. Their products are designed to treat conditions like epilepsy and Parkinson’s as well as chronic pain. As of now, the company …

Continue Reading

Posted in Articles| Tagged , , , , |

MJNA Numbers Don’t Lie This is a Company on the Rise

Medical Marijuana, Inc. has earned its title as a leader in the medical marijuana industry. It’s pioneering the way for more acceptance of medicinal marijuana as well as deriving revolutionary products. Today, the company is yet again proving itself and standing stronger than ever with record sales for a month.

Who is Medical Marijuana, Inc.?

Medical Marijuana, Inc, is a premier hemp and cannabis industry leader. With innovative ideas from experts in the field, the company is continuing to develop unique products that benefit overall health and wellness. The company focuses on creating awareness about the cannabis industry. The company develops environmentally-friendly and sustainable products. Additionally, Medical Marijuana, Inc. increases shareholder value with each and every product they develop.

Medical Marijuana, Inc. touts about being a company of firsts. It’s the first publicly traded cannabis company ever in the United States. Moreover, it’s the first direct sales and network …

Continue Reading

Posted in Articles| Tagged , , , , |

MJNA Offers the Ideal Option for Athletes in Massive Recovery Market

Medical Marijuana, Inc. is a company that carved out a significant section of a highly competitive market in 2016 and 2017, and it stands to gain even more traction on the international market in the years to come. A major international move for the company promises to expand its market share and yield new growth opportunities in a global sphere.

Medical Marijuana Markets in the United States

It is estimated that the legal marijuana industry has a value of $7.1 billion in the United States alone. This figure is expected to see continued growth throughout the remainder of 2017 and well into 2018 as the American public and medical community become more aware of the benefits of CBD oil products. While this figure includes both legal recreational and medicinal use in the United States, medical marijuana products show unprecedented potential for market growth due to their versatile treatment indications.



Continue Reading
Posted in Articles| Tagged , , , |

Medical Marijuana, Inc. Portfolio company KannaLife Sciences, Wraps Up Media Tour Discussing CTE in New York with New Spokesman, Nick Lowery

Former Kansas City Chiefs Placekicker spoke with Fox Business, CBS Sports, NBC and i24 News.

SAN DIEGO, Sept. 29, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, today announced that portfolio company KannaLife Sciences‘ new spokesman Nick Lowery and former Kansas City Chiefs placekicker, generated a massive amount of media coverage across the United States about the dangers of chronic traumatic encephalopathy (CTE).

CTE is a degenerative neurological disease caused by repeated head trauma and only diagnosable with certainty in post-mortem examinations and can lead to symptoms like violent mood swings, depression and other cognitive difficulties. Because there is not much known about this debilitating disease, treatment and prevention options are bleak.

A September 26, 2017 interview with Fox Business’ Varney & Co., discussed current research on the diagnosis and treatment of CTE, and its relationship to professional sports organizations …

Continue Reading

Posted in Client News| Tagged , , , |